J. Kevin Day

525 total citations
8 papers, 412 citations indexed

About

J. Kevin Day is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, J. Kevin Day has authored 8 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 3 papers in Genetics. Recurrent topics in J. Kevin Day's work include Phytoestrogen effects and research (3 papers), Nutrition, Genetics, and Disease (2 papers) and Estrogen and related hormone effects (2 papers). J. Kevin Day is often cited by papers focused on Phytoestrogen effects and research (3 papers), Nutrition, Genetics, and Disease (2 papers) and Estrogen and related hormone effects (2 papers). J. Kevin Day collaborates with scholars based in United States, United Kingdom and Singapore. J. Kevin Day's co-authors include Dennis B. Lubahn, Cynthia Besch‐Williford, Ruth S. MacDonald, Byung-Eun Kim, Andrew M. Bauer, Leslie G. Newton, Charles desBordes, Tim Hui-Ming Huang, Tim H-M. Huang and Frederick S. vom Saal and has published in prestigious journals such as The Lancet, Nature Materials and Endocrinology.

In The Last Decade

J. Kevin Day

7 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Kevin Day United States 7 215 140 108 60 57 8 412
Renea R. Eason United States 10 186 0.9× 120 0.9× 102 0.9× 76 1.3× 18 0.3× 12 390
Anne R. M. von Bergh Netherlands 10 305 1.4× 63 0.5× 24 0.2× 48 0.8× 41 0.7× 12 520
P. M. Gopinath India 12 184 0.9× 112 0.8× 44 0.4× 73 1.2× 72 1.3× 42 451
Prema Kolachana United States 10 261 1.2× 126 0.9× 107 1.0× 79 1.3× 26 0.5× 13 562
Anastasia Spyropoulou Greece 12 242 1.1× 53 0.4× 23 0.2× 48 0.8× 18 0.3× 27 481
Youyou Zhou China 12 203 0.9× 56 0.4× 31 0.3× 37 0.6× 46 0.8× 20 383
Abdelali Lehraiki France 10 296 1.4× 42 0.3× 57 0.5× 98 1.6× 40 0.7× 12 590
Rosanna Rinaldi Italy 11 201 0.9× 90 0.6× 26 0.2× 12 0.2× 36 0.6× 16 423
Gonca İmir United States 11 167 0.8× 522 3.7× 28 0.3× 91 1.5× 40 0.7× 16 1.6k
Kazuhisa Shimodaira Japan 14 189 0.9× 99 0.7× 20 0.2× 85 1.4× 49 0.9× 18 608

Countries citing papers authored by J. Kevin Day

Since Specialization
Citations

This map shows the geographic impact of J. Kevin Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Kevin Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Kevin Day more than expected).

Fields of papers citing papers by J. Kevin Day

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Kevin Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Kevin Day. The network helps show where J. Kevin Day may publish in the future.

Co-authorship network of co-authors of J. Kevin Day

This figure shows the co-authorship network connecting the top 25 collaborators of J. Kevin Day. A scholar is included among the top collaborators of J. Kevin Day based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Kevin Day. J. Kevin Day is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Li, Zhuangnan, et al.. (2026). Scalable manufacture of nearly pure-phase metallic MoS2 nanosheets. Nature Materials.
2.
Ślusarz, Anna, J. Kevin Day, Nader S. Shenouda, et al.. (2012). Aggressive Prostate Cancer Is Prevented in ERαKO Mice and Stimulated in ERβKO TRAMP Mice. Endocrinology. 153(9). 4160–4170. 45 indexed citations
3.
Day, J. Kevin, Andrew M. Bauer, Charles desBordes, et al.. (2002). Genistein Alters Methylation Patterns in Mice. Journal of Nutrition. 132(8). 2419S–2423S. 149 indexed citations
4.
Alworth, Leanne C., Kembra L. Howdeshell, Rachel L. Ruhlen, et al.. (2002). Uterine Responsiveness to Estradiol and DNA Methylation Are Altered by Fetal Exposure to Diethylstilbestrol and Methoxychlor in CD-1 Mice: Effects of Low versus High Doses. Toxicology and Applied Pharmacology. 183(1). 10–22. 89 indexed citations
5.
Day, J. Kevin, et al.. (2001). Dietary Genistein Increased DMBA-Induced Mammary Adenocarcinoma in Wild-Type, but Not ERαKO, Mice. Nutrition and Cancer. 39(2). 226–232. 51 indexed citations
6.
Schatten, Heide, Allison M. D. Wiedemeier, Dennis B. Lubahn, et al.. (2000). Centrosome‐centriole abnormalities are markers for abnormal cell divisions and cancer in the transgenic adenocarcinoma mouse prostate (TRAMP) model. Biology of the Cell. 92(5). 331–340. 35 indexed citations
7.
Day, J. Kevin, et al.. (1998). Identification of a novel missense mutation of the SMN T gene in two siblings with spinal muscular atrophy. Neurogenetics. 1(4). 273–276. 30 indexed citations
8.
Day, J. Kevin, et al.. (1972). POSSIBLE ROLE OF GLUCAGON IN PATHOGENESIS OF ACUTE PANCREATITIS. The Lancet. 299(7760). 1097–1099. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026